Clinical Trial Update: TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares transarterial chemoembolization plus radiofrequency ablation (TACE+RFA) against re-resection for recurrent small hepatocellula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Surgery | Phase 3 | Status: UNKNOWN